JULIAN
CARRETERO ASUNCION
TITULAR DE UNIVERSIDAD
INES
PULIDO ENDRINO
INVEST CONT VALi+d
Publikationen, an denen er mitarbeitet INES PULIDO ENDRINO (5)
2024
2022
-
A Very Rare Variant in SREBF2, a Possible Cause of Hypercholesterolemia and Increased Glycemic Levels
Biomedicines, Vol. 10, Núm. 5
2020
-
Endothelin-1-mediated drug resistance in EGFR-mutant non-small cell lung carcinoma
Cancer Research, Vol. 80, Núm. 19, pp. 4224-4232
2019
-
CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC
Cancer Research, Vol. 79, Núm. 17, pp. 4439-4452
2015
-
Intratumoral heterogeneity in EGFR-mutant NSCLC results in divergent resistance mechanisms in response to EGFR tyrosine kinase inhibition
Cancer Research, Vol. 75, Núm. 20, pp. 4372-4383